An acetanilide and piperazine derivative that functions as a SODIUM CHANNEL BLOCKER and prevents the release of enzymes during MYOCARDIAL ISCHEMIA. It is used in the treatment of ANGINA PECTORIS.
Ranolazine has been studied across 16 research domains including ❤️ Cardiovascular, 🔥 Metabolic, 🦴 Bone & Joint, 🔬 Inflammation, 🫘 Kidney. The primary research focus is ❤️ Cardiovascular with 33% of studies addressing this area.
The following compounds share molecular targets with Ranolazine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Ranolazine is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.